Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.
Mazzu YZ, Liao Y, Nandakumar S, Sjöström M, Jehane LE, Ghale R, Govindarajan B, Gerke TA, Lee GM, Luo JH, Chinni SR, Mucci LA, Feng FY, Kantoff PW.
Mazzu YZ, et al. Among authors: govindarajan b.
Mol Oncol. 2022 Jul;16(13):2451-2469. doi: 10.1002/1878-0261.13140. Epub 2022 Feb 11.
Mol Oncol. 2022.
PMID: 34792282
Free PMC article.